251 related articles for article (PubMed ID: 15481989)
1. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
[TBL] [Abstract][Full Text] [Related]
2. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
[TBL] [Abstract][Full Text] [Related]
3. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
[TBL] [Abstract][Full Text] [Related]
8. 2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.
Elzein E; Palle V; Wu Y; Maa T; Zeng D; Zablocki J
J Med Chem; 2004 Sep; 47(19):4766-73. PubMed ID: 15341491
[TBL] [Abstract][Full Text] [Related]
9. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
[TBL] [Abstract][Full Text] [Related]
10. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
12. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
[TBL] [Abstract][Full Text] [Related]
13. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
[TBL] [Abstract][Full Text] [Related]
14. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
Volpini R; Camaioni E; Costanzi S; Vittori S; Klotz KN; Cristalli G
Nucleosides Nucleotides; 1999; 18(11-12):2511-20. PubMed ID: 10639752
[TBL] [Abstract][Full Text] [Related]
17. 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
Biagi G; Bianucci AM; Coi A; Costa B; Fabbrini L; Giorgi I; Livi O; Micco I; Pacchini F; Santini E; Leonardi M; Nofal FA; Salerni OL; Scartoni V
Bioorg Med Chem; 2005 Aug; 13(15):4679-93. PubMed ID: 15908217
[TBL] [Abstract][Full Text] [Related]
18. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
[TBL] [Abstract][Full Text] [Related]
19. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
[TBL] [Abstract][Full Text] [Related]
20. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
